We also observed that BMDM differentiated from the BMC of orlistat-administered tumor-bearing mice showed augmented phagocytosis, tumoricidal activity, expression of cell surface receptors like CD11c, TLR-2 and production of ROS, NO, IL-1 and TNF-α. This evidence concerns the gene CD177 and neoplasm.